找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Melanoma; David E. Fisher,Boris C. Bastian Reference work 2019 Springer Science+Business Media, LLC, part of Springer Nature 2019 melanoma

[復(fù)制鏈接]
查看: 34122|回復(fù): 56
樓主
發(fā)表于 2025-3-21 18:55:10 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Melanoma
編輯David E. Fisher,Boris C. Bastian
視頻videohttp://file.papertrans.cn/631/630293/630293.mp4
概述Cutting-edge and comprehensive presentation of the field of melanoma.Written by a team of internationally renowned thought-leaders.Topics include recent breakthroughs in molecular diagnostics, breakth
圖書封面Titlebook: Melanoma;  David E. Fisher,Boris C. Bastian Reference work 2019 Springer Science+Business Media, LLC, part of Springer Nature 2019 melanoma
描述Melanoma is a cutting edge, comprehensive reference work on the topic of melanoma. The overarching goal is to provide detailed scholarly information which broadly covers all aspects of the clinical presentation and management of the disease, as well as the biological and scientific understanding of its pathogenesis and treatment. Key topics highlighted include recent breakthroughs in molecular diagnostics, breakthroughs in targeted therapeutic approaches, overviews of signaling and transcriptional pathways, and important controversies such as screening, early diagnosis, sentinel node biopsy, and prevention strategies. In all, the volume provides a cutting edge and comprehensive presentation of the field of melanoma, written by a team of internationally renowned thought-leaders.
出版日期Reference work 2019
關(guān)鍵詞melanoma; oncology; skin cancer; melanocytic neoplasm; clinical management
版次1
doihttps://doi.org/10.1007/978-1-4614-7147-9
isbn_ebook978-1-4614-7147-9
copyrightSpringer Science+Business Media, LLC, part of Springer Nature 2019
The information of publication is updating

書目名稱Melanoma影響因子(影響力)




書目名稱Melanoma影響因子(影響力)學(xué)科排名




書目名稱Melanoma網(wǎng)絡(luò)公開度




書目名稱Melanoma網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Melanoma被引頻次




書目名稱Melanoma被引頻次學(xué)科排名




書目名稱Melanoma年度引用




書目名稱Melanoma年度引用學(xué)科排名




書目名稱Melanoma讀者反饋




書目名稱Melanoma讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

1票 100.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:55:12 | 只看該作者
Craig Sinclair,Louise F. Wilson,Catherine Olsen,Anna Nicholson
板凳
發(fā)表于 2025-3-22 02:46:46 | 只看該作者
地板
發(fā)表于 2025-3-22 05:45:21 | 只看該作者
Developmental Biology of Melanocytesupon tumor initiation in a zebrafish model of melanoma, suggesting a functional involvement of a NCSC program in tumors originating from neural crest derivatives. Thus, to gain insights into melanoma biology, it is important to understand the mechanisms regulating NCSC and melanocyte development, as
5#
發(fā)表于 2025-3-22 08:59:03 | 只看該作者
6#
發(fā)表于 2025-3-22 14:30:07 | 只看該作者
Key Signaling Pathways in Normal and Neoplastic Melanocyteskinase signaling are also frequent in melanoma and promote aberrant cell cycle progression. Other pathways such as Gαq, Wnt (canonical and noncanonical), Hippo, Notch, and signaling downstream of Rho family GTPases also play important roles in the aforementioned biological processes, and in some cas
7#
發(fā)表于 2025-3-22 17:49:44 | 只看該作者
8#
發(fā)表于 2025-3-23 00:47:50 | 只看該作者
Melanoma Metabolismh suggests that the events required to transform cells to malignancy must allow cells to meet their biosynthetic and bioenergetic needs. During progression, melanomas appear to display metabolic heterogeneity as vital nutrient sources become scarce and the tumor seeks to overcome these restrictions.
9#
發(fā)表于 2025-3-23 03:26:17 | 只看該作者
10#
發(fā)表于 2025-3-23 09:23:27 | 只看該作者
Principles of Targeted Therapyment. ERK inhibitors are currently undergoing clinical development. KIT mutations are primarily found in acral and mucosal melanomas, and several KIT inhibitors have been tested in KIT-mutant melanoma clinical trials; so far none have been approved by regulatory agencies. The challenge for KIT inhib
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 23:41
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
宿松县| 崇明县| 雅安市| 蒲城县| 教育| 古浪县| 当涂县| 普陀区| 景谷| 买车| 千阳县| 新营市| 泸水县| 阳新县| 瑞昌市| 高密市| 太和县| 双牌县| 寿阳县| 和平县| 忻州市| 宜宾市| 平顺县| 富顺县| 东丰县| 长岛县| 砚山县| 阿克苏市| 信宜市| 疏附县| 大同市| 新沂市| 乌兰浩特市| 广东省| 潼关县| 田林县| 芦山县| 桑植县| 大冶市| 鄂尔多斯市| 庆云县|